knowledge -WSS

knowledge

author：Wikipedia 2025-09-03 03:28:59 - browse：5534

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： GSK Flovent asthma inhalers replaced by authorized generics

Wikipedia

WSS

U.K. sequencing study surfaces new findings about tumor DNA

The biotech scorecard for Q1: 17 stock

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

U.K. sequencing study surfaces new findings about tumor DNA

GSK Flovent asthma inhalers replaced by authorized generics

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

hotspot

knowledge

leisure time

Activists slam private health insurers over coverage restrictions

Federal weight loss drug coverage is 30 years out of date

Hepatitis C has a cure — but many Americans still lack access to it

Diversity in medical illustrations gets boost from Chidiebere Ibe

ChatGPT in medicine: STAT answers readers' burning questions

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Feng Zhang, Grail founder join forces on new gene editing startup

Bright Health sells Medicare Advantage business to Molina

JPM: CVS says Medicare Advantage patients are impacting profits

focus

J&J to buy cancer drug developer Ambrx Biopharma

3 medical device trends to watch in 2024

Ahead of JPM, here's who's profiting most in health care

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

As pharma fights Medicare drug negotiation, hospitals, docs silent

U.K. sequencing study surfaces new findings about tumor DNA

hotspot

focus

Wikipedia

Wikipedia